Private Equity Firm Healthcare

Amulet Capital Partners

Greenwich, Connecticut, United States

Amulet Capital is a middle-market private equity investment firm based in Greenwich, CT that focuses exclusively on the healthcare sector. The firm seeks to create significant value by working with strong management teams and investing across a wide range of transaction structures in both public and private companies.

Focus Areas
Healthcare, Life Sciences, Healthcare Services

Tracked deals

16

16 tracked deals across 2020-2026.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Buyout

7 buyout · 6 addon · 2 growth capital

Amulet Capital Partners Acquisition Volume by Year

Last 6 years

Acquisition volume by year Annual acquisition counts for the last 6 years for Amulet Capital Partners. 2 2020 2 2021 3 2022 5 2023 3 2024 ~1 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

Showing the 12 most recent of 16 tracked deals for Amulet Capital Partners.

  • Buyer
    Amulet Capital Partners
    Target
    TFP Fertility Group
    Seller
    Benefit Street Partners (BSP)
    Location
    United Kingdom
    Type
    Buyout

    Amulet Capital Partners announced it has acquired TFP Fertility Group, a fertility care provider operating clinics across the UK and Northern Europe, from Benefit Street Partners. TFP will continue to operate under the TFP brand with no changes to its clinical leadership, led by CEO Jude Fleming.

  • Buyer
    Amulet Capital Partners
    Target
    Theoria Management, LLC
    Type
    Buyout

    Amulet Capital Partners has made a new platform investment in Theoria Management, a tech-enabled management services organization that delivers on-site and virtual value-based primary care to senior living and post-acute communities. Theoria's founder Justin Di Rezze will remain CEO and a significant shareholder; financial terms were not disclosed.

  • Buyer
    Minds + Assembly, Amulet Capital Partners
    Target
    BOLDSCIENCE
    Type
    Addon

    Minds + Assembly has joined forces with BOLDSCIENCE, adding the medical communications agency to its Amulet Capital Partners–backed healthcare communications platform. The deal brings BOLDSCIENCE’s ~200-person scientific communications team into the Minds + Assembly platform to broaden capabilities across medical affairs, publications, and scientific communications and accelerate the platform’s end-to-end commercialization offering.

  • Buyer
    Amulet Capital Partners, LP, Amulet Limited Partners (co-investor consortium)
    Target
    Genetics & IVF Institute
    Type
    Buyout

    Amulet Capital Partners has acquired the Genetics & IVF Institute (GIVF), a leading provider of reproductive tissue banking and related reproductive technology services, including Fairfax Cryobank and Fairfax EggBank. The private equity investment—made with significant co-investment from a consortium of Amulet limited partners—will support GIVF's growth, platform and capability expansion to broaden access to fertility services and donor-tissue offerings.

  • Buyer
    Unlock Health, Amulet Capital Partners, Athyrium Capital Management
    Target
    SPM Group (including SPM, GLC, Dreamscape, Centretek)
    Seller
    Corridor Capital
    Location
    United States
    Type
    Addon

    Unlock Health, a healthcare technology and services growth platform backed by Amulet Capital Partners and Athyrium Capital Management, has acquired SPM Group — a network of health-focused agencies including SPM, GLC, Dreamscape and Centretek — from Corridor Capital. The deal (terms not disclosed) expands Unlock Health's in-house omnichannel media planning, buying, creative, analytics and managed care consulting capabilities and increases scale across healthcare provider, behavioral health and dental end markets.

  • Buyer
    Amulet Capital Partners, LP
    Target
    Alliance Clinical Network
    Type
    Buyout

    Amulet Capital Partners has acquired Alliance Clinical Network (ACN), a Dallas-based clinical site platform that owns and operates six research sites across California, Nevada and Texas. ACN will continue to be led by founder and CEO Anthony Abey (who retains a significant ownership stake) and will partner with Amulet to expand its footprint, therapeutic capabilities and strategic acquisitions to serve pharmaceutical sponsors and CROs.

  • Buyer
    Amulet Capital Partners
    Target
    minds + assembly

    Amulet Capital Partners has made a significant growth investment in minds + assembly, a New York–based full-service, design-centric healthcare commercialization and creative agency. The investment will support m+a's expansion of analytics and media capabilities and provide resources to scale while the company's founders remain significant shareholders; financing was provided by Audax Private Debt.

  • Buyer
    US Fertility, Amulet Capital Partners
    Target
    Ovation Fertility
    Seller
    Morgan Stanley Capital Partners
    Type
    Addon

    US Fertility, the physician-led fertility practice management platform backed by Amulet Capital Partners, has acquired Ovation Fertility from investment funds managed by Morgan Stanley Capital Partners. The deal combines Ovation’s IVF laboratories and ancillary services with US Fertility’s physician network to create a national fertility platform aimed at expanding access, sharing best practices, and improving patient outcomes; financial terms were not disclosed.

  • Buyer
    Amulet Capital Partners, Athyrium Capital Management
    Target
    Eruptr
    Seller
    H.I.G. Growth Partners
    Type
    Buyout

    Amulet Capital Partners has acquired Eruptr, a Bradenton, Florida–based provider of technology-enabled healthcare digital marketing and SaaS health risk assessments, with Athyrium Capital Management investing alongside Amulet. Eruptr was previously a portfolio company of H.I.G. Growth Partners; the deal positions Eruptr to expand its patient acquisition, engagement and SaaS offerings under Amulet's healthcare-focused platform.

  • Buyer
    Amulet Capital Partners, LP
    Target
    United Vein & Vascular Centers
    Type
    Buyout

    Amulet Capital Partners, a middle-market healthcare-focused private equity firm, has acquired United Vein & Vascular Centers (UVVC), a Tampa-based provider of outpatient vascular care operating more than 30 clinic locations. Amulet will partner with founder and CEO Dr. Gamal Wazni and management to expand UVVC’s national footprint, add new clinics and broaden its treatment capabilities.

  • Buyer
    Amulet Capital Partners, LP
    Target
    Lighthouse Behavioral Health Solutions

    Amulet Capital Partners has recapitalized Lighthouse Behavioral Health Solutions, a Columbus, Ohio-based network of outpatient substance use disorder and mental health treatment facilities. The recapitalization will provide financial support to accelerate Lighthouse's growth and expand access to outpatient treatment, recovery housing, and peer-support services across Ohio; terms were not disclosed.

  • Buyer
    US Fertility, Shady Grove Fertility (SGF), Amulet Capital Partners
    Target
    Center of Reproductive Medicine (CORM)
    Type
    Addon

    Center of Reproductive Medicine (CORM), a Houston-based fertility center, has entered a partnership with US Fertility and will adopt the Shady Grove Fertility (SGF) name to become SGF Houston. The deal expands US Fertility/SGF's clinical footprint in Texas and is part of the platform's physician-led roll-up backed by Amulet Capital Partners; terms were not disclosed.

Related Acquisition Pages

Selling a company? Get in front of buyers like Amulet Capital Partners

Turn tracked acquisition activity into an outreach-ready buyer list.